VALENCIA, Calif., June 29, 2026 /PRNewswire/ -- Bioness Medical, Inc. ("Bioness", or the "Company"), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies ...
ST. LOUIS, June 30, 2026 /PRNewswire/ -- Aurenar, developer of a non-invasive neuromodulation platform for patients in intensive care, today announced that the U.S. Food and Drug Administration (FDA) ...
VALENCIA, Calif., April 9, 2026 /PRNewswire/ -- Bioness Medical, Inc. ("Bioness", or the "Company"), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies ...
AUSTIN, Texas--(BUSINESS WIRE)--Surf Therapeutics, a clinical-stage neuro-immunomodulation company developing non-invasive ultrasound therapy for chronic inflammatory diseases, is announcing the start ...
Aurenar, maker of a non-invasive neuromodulation platform for intensive care unit patients, closed an oversubscribed $5.7 million seed financing round. The Go Red for Women Venture Fund, part of ...
This project was supported by contracts between the National Academy of Sciences and the Alzheimer’s Association; Brain Canada Foundation; the Department of Health and Human Services’ Food and Drug ...
Emerging neurotechnologies—devices and techniques designed to collect information about the brain or affect its function—are becoming increasingly important due to scientific and technological ...
My brain injury in 2000 affected my balance and gait. Doctors assessed it by asking me to walk across a small room and back again. Aside from that observational method, which would not have apprised ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, today announced new results from a ...
A new non-invasive brain stimulation technology is bringing fresh hope to patients and families dealing with Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results